The store will not work correctly when cookies are disabled.
(5-Amino-3-(phenylamino)-1H-1,2,4-triazol-1-yl)(phenyl)-methanone
ID: ALA4755409
PubChem CID: 125464900
Max Phase: Preclinical
Molecular Formula: C15H13N5O
Molecular Weight: 279.30
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1nc(Nc2ccccc2)n[nH]1)c1ccccc1
Standard InChI: InChI=1S/C15H13N5O/c21-13(11-7-3-1-4-8-11)17-15-18-14(19-20-15)16-12-9-5-2-6-10-12/h1-10H,(H3,16,17,18,19,20,21)
Standard InChI Key: JSXAZVPBIUDZNM-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
28.5167 -21.1555 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.1648 -20.6578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8934 -19.8869 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.0740 -19.9083 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8452 -20.6919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9481 -20.8905 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.0751 -20.9653 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.4533 -20.4351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6060 -19.6325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9849 -19.1025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2139 -19.3759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0675 -20.1841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6897 -20.7106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5413 -20.3284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3247 -20.5611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3512 -19.5337 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.5126 -21.3540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2951 -21.5868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8893 -21.0245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6955 -20.2262 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9133 -19.9972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 2 0
5 1 1 0
2 6 1 0
5 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 8 1 0
6 14 1 0
14 15 1 0
14 16 2 0
15 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 15 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 279.30 | Molecular Weight (Monoisotopic): 279.1120 | AlogP: 2.80 | #Rotatable Bonds: 4 |
Polar Surface Area: 82.70 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.34 | CX Basic pKa: 0.38 | CX LogP: 3.49 | CX LogD: 3.48 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.69 | Np Likeness Score: -1.55 |
References
1. Korff M,Imberg L,Will JM,Bückreiß N,Kalinina SA,Wenzel BM,Kastner GA,Daniliuc CG,Barth M,Ovsepyan RA,Butov KR,Humpf HU,Lehr M,Panteleev MA,Poso A,Karst U,Steinmetzer T,Bendas G,Kalinin DV. (2020) Acylated 1H-1,2,4-Triazol-5-amines Targeting Human Coagulation Factor XIIa and Thrombin: Conventional and Microscale Synthesis, Anticoagulant Properties, and Mechanism of Action., 63 (21): [PMID:33089691] [10.1021/acs.jmedchem.0c01635] |